Related references
Note: Only part of the references are listed.Nalfurafine hydrochloride, a selective κ opioid receptor agonist, has no reinforcing effect on intravenous self-administration in rhesus monkeys
Kaoru Nakao et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2016)
The hallucinogenic diterpene salvinorin A inhibits leukotriene synthesis in experimental models of inflammation
Antonietta Rossi et al.
PHARMACOLOGICAL RESEARCH (2016)
Synthesis and Characterization of a Dual Kappa-Delta Opioid Receptor Agonist Analgesic Blocking Cocaine Reward Behavior
Andras Varadi et al.
ACS CHEMICAL NEUROSCIENCE (2015)
Nalfurafine Suppresses Pruritogen- and Touch-evoked Scratching Behavior in Models of Acute and Chronic Itch in Mice
Tasuku Akiyama et al.
ACTA DERMATO-VENEREOLOGICA (2015)
Novel κ-opioid receptor agonist MB-1C-OH produces potent analgesia with less depression and sedation
Le-sha Zhang et al.
ACTA PHARMACOLOGICA SINICA (2015)
Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1-Dependent Withdrawal
Liting Deng et al.
BIOLOGICAL PSYCHIATRY (2015)
Pharmacology and anti-addiction effects of the novel kappa opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin A
B. Simonson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
The G Protein-Biased kappa-Opioid Receptor Agonist RB-64 Is Analgesic with a Unique Spectrum of Activities In Vivo
Kate L. White et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
A simplified up-down method (SUDO) for measuring mechanical nociception in rodents using von Frey filaments
Robert P. Bonin et al.
MOLECULAR PAIN (2014)
The individual and societal burden of chronic pain in Europe: the case for strategic prioritisation and action to improve knowledge and availability of appropriate care
Harald Breivik et al.
BMC PUBLIC HEALTH (2013)
One year long-term study on abuse liability of nalfurafine in hemodialysis patients
Yuji Ueno et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2013)
Why Patients Visit Their Doctors: Assessing the Most Prevalent Conditions in a Defined American Population
Jennifer L. St Sauver et al.
MAYO CLINIC PROCEEDINGS (2013)
Opioid receptors: toward separation of analgesic from undesirable effects
Ping-Yee Law et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
A single injection of a novel kappa opioid receptor agonist salvinorin A attenuates the expression of cocaine-induced behavioral sensitization in rats
Aashish S. Morani et al.
BEHAVIOURAL PHARMACOLOGY (2012)
Dose-Related Behavioral, Subjective, Endocrine, and Psychophysiological Effects of the κ Opioid Agonist Salvinorin A in Humans
Mohini Ranganathan et al.
BIOLOGICAL PSYCHIATRY (2012)
Antinociceptive effects of herkinorin, a MOP receptor agonist derived from salvinorin A in the formalin test in rats: New concepts in mu opioid receptor pharmacology: From a symposium on new concepts in mu-opioid pharmacology
Kenneth Lamb et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors
Jakub Fichna et al.
INFLAMMATORY BOWEL DISEASES (2012)
Indigenous New Zealand honeys exhibit multiple anti-inflammatory activities
Aidan G. Leong et al.
INNATE IMMUNITY (2012)
The Economic Costs of Pain in the United States
Darrell J. Gaskin et al.
JOURNAL OF PAIN (2012)
Salvinorin A reduces mechanical allodynia and spinal neuronal hyperexcitability induced by peripheral formalin injection
Francesca Guida et al.
MOLECULAR PAIN (2012)
The kappa opioid receptor agonist SA14867 has antinociceptive and weak sedative effects in models of acute and chronic pain
Yaeko Tsubahara-Ohsumi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo
Gabriella Aviello et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Potential drug abuse therapeutics derived from the hallucinogenic natural product salvinorin A
Katherine M. Prevatt-Smith et al.
MEDCHEMCOMM (2011)
Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study
Hiroo Kumagai et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Antinociceptive effect of three common analgesic drugs on peripheral neuropathy induced by paclitaxel in rats
David Pascual et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Kappa opioids and the modulation of pain
Bronwyn Kivell et al.
PSYCHOPHARMACOLOGY (2010)
Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents
Daniela Braida et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen
Zeynep S. Teksin et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Effects of Atypical kappa-Opioid Receptor Agonists on Intrathecal Morphine-Induced Itch and Analgesia in Primates
Mei-Chuan Ko et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Unconditioned Behavioral Effects of the Powerful κ-Opioid Hallucinogen Salvinorin A in Nonhuman Primates: Fast Onset and Entry into Cerebrospinal Fluid
Eduardo R. Butelman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats
Aashish S. Morani et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Antinociceptive and Adverse Effects of μ- and κ-Opioid Receptor Agonists: A Comparison of Morphine and U50488-H
Elizabeth L. Gallantine et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2008)
Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats
Elizabeth J. Rahn et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans
Jacob M. Hooker et al.
NEUROIMAGE (2008)
The antinociceptive effect of Salvinorin A in mice
Trentini F. John et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
H Breivik et al.
EUROPEAN JOURNAL OF PAIN (2006)
Anti-inflammatory effects of contralateral administration of the κ-opioid agonist U-50,488H in rats with unilaterally induced adjuvant arthritis
I Bileviciute-Ljungar et al.
RHEUMATOLOGY (2006)
Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: A preliminary prospective study
LF Chu et al.
JOURNAL OF PAIN (2006)
Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist
CR McCurdy et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2006)
Psychopharmacology of the hallucinogenic sage Salvia divinorum
TE Prisinzano
LIFE SCIENCES (2005)
Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients
PM Dougherty et al.
PAIN (2004)
Salvinorin A, an active component of the hallucinogenic sage Salvia divinorum is a highly efficacious κ-opioid receptor agonist:: Structural and functional considerations
C Chavkin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Antidepressant-like effects of κ-opioid receptor antagonists in the forced swim test in rats
SD Mague et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Salvinorin A:: A potent naturally occurring nonnitrogenous κ opioid selective agonist
BL Roth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Analgesic and antiinflammatory effects of two novel κ-opioid peptides
W Binder et al.
ANESTHESIOLOGY (2001)
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
LM Bohn et al.
NATURE (2000)
Characterization of the antinociceptive effects of TRK-820 in the rat
T Endoh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Share Paper
